CEO, Board Member
John has over 2 decades of experience co-founding and building hard technology-based companies leading from inception to exit. He holds an economics degree from Duke University and Immunology Ph.D. from the University of Chicago. He is a former Investment associate of ARCH Venture partners (Hard tech industries); Founder and CEO of Ancora Pharmaceuticals which was acquired by Corden Pharma in 2012. John raised over $75MM as co-founder, executive and board member.